FTT 0.00% 0.5¢ factor therapeutics limited

Procedural Mistakes or lack of public information's in reference to the EU andFDA Trial, page-22

  1. 427 Posts.
    lightbulb Created with Sketch. 7
    Thank you Southoz for your quality information and perspective.


    The data in the chart you supplied, was that made available to the market, and is it possible to get all the individual data anywhere?


    I don't recall seeing that anywhere. I just seem to recall that the average age was 3 years and were difficult to treat patients with an average age of 74 years.


    With a spread like what you have shown, including a 100 year old patient that had a wound for 30 years with a size of 32 cm2 then you can certainly average it right out.


    Of course the person 49 years of age with a wound 1 month old and a size of 1.8 cm2 is going to heal.


    What did the rest look like, how many extremely old patients with long duration ulcers and size were used to drag out the average age, wound size and duration. 


    Is such information available to shareholders?


    I have little doubt that what was done and disclosed was technically legal, however if the rest of the data is along the lines of what I am beginning to suspect then it should have been picked up by the new management to be questionable. 

 
watchlist Created with Sketch. Add FTT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.